SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-002684
Filing Date
2023-03-02
Accepted
2023-03-02 16:16:15
Documents
91
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K knsa-20221231x10k.htm   iXBRL 10-K 3531011
2 EX-23.1 knsa-20221231xex23d1.htm EX-23.1 1949
3 EX-31.1 knsa-20221231xex31d1.htm EX-31.1 14212
4 EX-31.2 knsa-20221231xex31d2.htm EX-31.2 14155
5 EX-32.1 knsa-20221231xex32d1.htm EX-32.1 7688
6 EX-32.2 knsa-20221231xex32d2.htm EX-32.2 7602
7 GRAPHIC knsa-20221231x10k006.jpg GRAPHIC 73241
8 GRAPHIC knsa-20221231x10k008.jpg GRAPHIC 71350
  Complete submission text file 0001558370-23-002684.txt   12949565

Data Files

Seq Description Document Type Size
9 EX-101.SCH knsa-20221231.xsd EX-101.SCH 80723
10 EX-101.CAL knsa-20221231_cal.xml EX-101.CAL 77255
11 EX-101.DEF knsa-20221231_def.xml EX-101.DEF 380577
12 EX-101.LAB knsa-20221231_lab.xml EX-101.LAB 706058
13 EX-101.PRE knsa-20221231_pre.xml EX-101.PRE 555434
85 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20221231x10k_htm.xml XML 2200828
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38492 | Film No.: 23699136
SIC: 2834 Pharmaceutical Preparations